Diagnostic challenges often arise when multiple central nervous system (CNS) lesions not accessible to biopsy are present on Magnetic Resonance Imaging (MRI). The differential diagnosis is broad, particularly in the context of exposure to steroids and/or in the setting of immunosuppression. Benign lesions to be considered are demyelinating diseases, sarcoidosis and other granulomatous diseases, and infectious diseases such as toxoplasmosis in immunocompromised patients and tuberculosis. Malignant lesions include CNS lymphoma, glioblastoma multiforme and brain metastases. The authors describe the clinical case of a 75-year-old woman with systemic lupus erythematosus (SLE), chronically medicated with Hydroxychloroquine 400 mg, Deflazacort 9 mg and Azathioprine 25 mg daily, who presented to the hospital with a 5-month history of progressive neurological deficits. It was particularly challenging, because the patient was immunocompromised, had multiple CNS lesions that were not accessible to biopsy and chronic therapy with corticosteroids altered the radiological pattern on brain MRI, masquerading the diagnosis. By writing up this case and review of the literature, further evidence is provided for loss of distinctive histological and radiographic findings of CNS lesions on steroid therapy, with a potential delay in diagnosis and subsequent worse prognosis.
Introduction
Diagnostic challenges may arise when multiple CNS lesions not accessible to biopsy are present on brain MRI. The differential diagnosis is broad, particularly in the context of exposure to steroids and/or in the setting of immunosuppression. Benign lesions to be considered are demyelinating diseases; sarcoidosis or other granulomatous diseases; and infectious diseases, especially toxoplasmosis in immunocompromised patients, tuberculosis and other space-occupying lesions caused by infectious pathogens. Malignant lesions include CNS lymphoma, glioma (more commonly higher grade lesions, such as glioblastoma multiforme), and metastases. The clinical setting in which the lesions occur and the presence of extra-CNS symptoms are important for differential diagnosis considerations. Etiological investigation needs to be carefully planned in order to be diagnosis-specific and cost effective 1 . One of the most common diagnostic challenges is the ability to reach a definitive diagnosis when corticosteroids have already been administered. These drugs are the empirical treatment given in most settings, but response to steroids does not necessarily confirm the diagnosis, sin-ce several conditions including CNS demyelinating disease, sarcoidosis, lymphoma, metastatic carcinoma and glioma, all show a positive response 2, 3 . By writing up this clinical case and review of the literature, further evidence is provided for the loss of distinctive histological and radiographic findings of CNS lesions on steroid therapy, with a potential delay in diagnosis and subsequent worse prognosis.
Case report
A 75-year-old Caucasian woman presented to the Emergency Room with a 5-month clinical history of progressive neurological symptoms, including sudden changes of mood and behaviour, confusion, impaired long-term memory, personality changes, slurred speech, left facial palsy, decreased muscle strength and sensitivity on the right limbs and unbalanced gait. Two months after symptom onset, the patient had performed a brain MRI, which was completely normal.
Relevant medical background included systemic lupus erythematosus (SLE), diagnosed at the age of 63 and with a benign course (SLEDAI:0/SLICC:1); stage 2 chronic kidney disease; essential systemic arterial hypertension; pulmonary silicosis and pulmonary Chest computed tomography (CT) scan was sugges-tive of silicosis with massive fibrosis. Brain MRI (figure 1) depicted multiple hyperintense lesions on T2-weighted sequences located bilaterally in the frontal and occipital white matter, the posterolateral aspects of the fourth ventricle, the splenium of the corpus callosum, the right middle cerebellar peduncle and the cisternal portion of the right trigeminal nerve. All these lesions showed enhancement on post-contrast axial T1 spin-echo images. There was also evidence of bilateral medial thalamic enhancing lesions. No diffusion-weighted imaging (DWI) sequence was performed on this study. These findings were not specific of any diagnosis but raised suspicion for one of three major groups of pathologies: lymphomas, non-infectious granulomatous diseases and infectious diseases.
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Because of the immunosuppression status of the patient, the previous history of pulmonary tuberculosis, the development of progressive focal neurological deficits, the presence of CSF mononuclear pleocytosis and hyperproteinorraquia and the MRI lesions described above, the possibility of tuberculous meningitis was considered. Quadruple tuberculostatic therapy plus dexamethasone 24 mg/day was started empirically, along with bacterial meningitis empirical treatment with Ceftriaxone, Ampicillin and Acyclovir. The last two were suspended within two days, as the results for Listeria monocytogenes and Herpes simplex viruses 1 and 2 DNA in the CSF were negative. More CSF analysis results were then available ( 
Discussion
Primary central nervous system lymphomas (PCNSLs) are extranodal non-Hodgkin´s lymphomas (NHLs) that affect primarily the CNS 2,4 . PCNSL presents with single or multiple brain parenchyma supratentorial lesions, with involvement of the posterior fossa being much less frequent (13%) and diffuse leptomeningeal involvement occurring only in a small minority of patients. Age appears to be a significant risk factor, as the incidence of the disease increases in the elderly population. PCNSLs are highly proliferative tumours, with a proliferation index of more than 50% in most cases, which can lead rapidly to death if diagnosis and/or the start of treatment is delayed 4,6 . Risk factors in immunocompetent patients are unknown, but long term immunosuppressive therapy or an underlying disease with associated immunosuppression are significant risk factors 7 . Lymphomagenesis is thought to be promoted by sustained antigenic stimulation by autoimmune diseases (such as SLE, Sjögren´s syndrome or rheumatoid arthritis) and/or by direct transforming properties of infectious agents 2, 8, 9 . CNS lymphomas developing in immunocompromised individuals are typically B-cell neoplasms, mostly DLBCL, and are EBV-positive (>95% vs 0%-20% in immunocompetent patients) 3, 9 . As in most CNS lymphomas developing in immunocompromised individuals, this patient was diagnosed with a DLBCL, and was EBV-positive. PCNSL presents with progressive encephalopathy or focal neurologic deficits that reflect the location of the lesions. 3, 4, 13 . Diffuse enhancing supraand/or infratentorial pachymeninges and extension along the ependymal surfaces can be detected with contrast-enhanced MRI in a subset of patients (3-5%), indicating leptomeningeal infiltration by tumour cells. Diffusion-weighted imaging and DWI-derived apparent diffusion coefficient (ADC) provide additional diagnostic information. Due to the hypercellularity of PCNSL the diffusion rate of unbound extracellular water molecules is restricted. Therefore, untreated PCNSLs are frequently hyperintense on DWI and hypointense on ADC maps. PCNSL in immunocompromised patients presents with greater radiological variability. These patients frequently have multiple lesions at diagnosis. Additionally, non-enhancing lesions and irregular or ring enhancement patterns, in addition to haemorrhage and necrosis, often occur in these patients 2, 4, 8 . Although there is no pathognomonic brain MRI pattern of PCNSL, these non-specific radiological features allow the differentiation of PCNSL from other brain tumours, such as metastases or glioblastoma multiforme, and inflammatory CNS diseases, including demyelinating lesions, neurosarcoidosis, and infectious conditions, particularly toxoplasmosis 1 . In conclusion, conventional and contrastenhanced MRI, including DWI and ADC-maps, remain the imaging procedures of choice in PCNSL, despite promising advanced imaging techniques, i.e. MR-spectroscopy, perfusion imaging, diffusion tensor imaging and fludeoxyglucose-PET, that may serve as adjunct diagnostic tools 1, 8, 13, 14 .
A lumbar puncture should be performed unless contraindicated and CSF examined for cell count, glucose, protein, cytology, flow cytometry, and immunoglobulin heavy-chain (IgH) and T-cell receptor (TCR) gene rearrangement analysis by polymerase chain reaction (PCR) 10, 11, 12 . Despite significant advances in cellular analyses and cytopathological examination of the CSF being regarded as gold standard for the diagnosis, CSF evaluation is diagnostic in only a minority of patients with suspected CNS lymphomas. Indeed, the Multiple central nervous system lesions on chronic corticosteroid therapy -a diagnostic challenge (revised version) CASO CLÍNICO Figure 2 . Second magnetic resonance imaging: axial T2 FLAIRdecreased size of the bilateral hyperintense lesions posterolateral to the IVth ventricle involving the cisternal portion of the right trigeminal nerve (a) which showed to be hyperintense on axial DWI (Diffusion-Weighted Imaging) (b) with low ADC indicating restricted diffusion on these lesions. sensitivity and specificity of cytopathology are low, mainly because of the paucity of tumour cells in CSF, the morphological similarity of lymphoma cells with reactive lymphocytes, which may also be significantly enlarged with blast-like nuclei, and by the upfront use of corticosteroids. However, the diagnostic yields may be improved by repeated lumbar punctures. In addition, modern technologies, including cellular immunophenotyping by flow cytometry and molecular genetic analyses of CSF, have successfully been advanced to facilitate the diagnosis of leptomeningeal disease in lymphoma. In most cases, additional immunocytochemistry is needed (using pan-B cell markers, e.g. CD20, CD10, BCL6, MUM1 and MIB1). Flow cytometry has the major advantage of reliably detecting small cell populations. Based on size, granularity, and antigen expression pattern, flow cytometry permits distinguishing between lymphoma cells and reactive lymphocytes. In a recent study, CSF specimens from 30 PCNSL patients were analysed by both cytopathology and multiparameter flow cytometry, demonstrating an increase in sensitivity from 13.3% to 23.3% for cytopathology and flow cytometry, respectively 15 . PCNSL carries rearranged and somatically mutated immunoglobulin genes with evidence for ongoing mutation. Thus, PCR analysis of immunoglobulin heavy and light chain genes may be extremely useful when morphology does not provide a conclusive diagnosis, particularly for those patients with corticoid mitigated lymphoma. In these cases, PCR may still detect a monoclonal B-cell population with somatically mutated immunoglobulin genes. This technique would have been useful in our particular clinical case. The establishment of novel CSF markers, including lymphoma associated proteins and molecular genetic markers, such as microRNAs (the expression of which is deregulated in various malignancies, including lymphoma), will improve the clinical relevance of lumbar puncture and CSF analysis further 2,3,8,12 . Currently, histological diagnosis of PCNSL remains mandatory to plan adequate treatment, with stereotactic biopsy of a brain parenchymal lesion or vitrectomy in patients with intraocular involvement. Patients in poor clinical condition and with space occupying CNS lesions resulting in intracranial hypertension are an exception and have to be treated without prior histopathological diagnosis. However, it is necessary to stress that the most important factor reducing the rate of a conclusive histological diagnosis is corticosteroid administration prior to biopsy 4, 3, 11 . Corticosteroid therapy is the first line of treatment for PSN-CL, although it should not be initiated before a definitive diagnosis in clinically stable patients is established. Steroids cause a rapid decrease in tumour size and peritumoral edema through a direct lymphocytolytic effect that may disrupt cellular morphology and lead to diagnostic inaccuracy at the time of microscopic analysis. Also, steroids may complicate the interpretation of gadolinium-enhanced MRI, because the abnormal contrast enhancement typically observed can decrease or even disappear. Clinical improvement and reduced MRI lesion enhancement under corticosteroid treatment are highly suggestive of CNS lymphoma, although these can also be observed in demyelinating disorders, vasculitis, sarcoidosis or, more rarely, in metastatic carcinoma or glioma 2, 4, 3, 12, 16 . This clinical case was particularly challenging, because the patient was immunocompromised, had multiple lesions not accessible to biopsy, and corticosteroid therapy had reduced lesion contrast enhancement on brain MRI, via the profound apoptotic effect of corticosteroids on lymphoma cells ("vanishing lymphoma" phenomenon), masquerading and delaying the diagnosis of PCNSL. Most patients initially respond to steroids, but relapses are frequent and additional chemotherapy should be promptly initiated in most patients, after histological diagnosis is achieved. Age is a prominent prognostic factor and older patients (>65 years of age) have a low rate of long-term survival, which must be taken into consideration when establishing a therapeutic plan. Median survival in this age group with best supportive care is only approximately 9 months 3,4,6 . As reported in literature, the clinical course of our patient was aggressive, and she died 7 months after the first symptoms.
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